NLRP3 and lung carcinoma: Emerging evidence supports the pivotal role of aberrantly activated inflammasomes, including NLRP3 (nucleotide-binding oligomerization domain, leucine-rich repeat and pyrin domain-containing protein 3), in lung cancer pathogenesis5,6.